License and Development AgreementLicense and Development Agreement • May 19th, 2008 • Avant Immunotherapeutics Inc • In vitro & in vivo diagnostic substances • New York
This License and Development Agreement (this “Agreement”) dated as of April 16, 2008 between Celldex Therapeutics, Inc., a Delaware corporation and wholly-owned subsidiary of Avant Immunotherapeutics, Inc., a Delaware corporation (“Avant”), with offices located at 222 Cameron Drive, Suite 400, Phillipsburg, New Jersey 08865 (“Celldex”), and Pfizer Vaccines LLC, a Delaware limited liability company with offices located at 235 East 42nd Street, New York, New York 10017-5755 (“Pfizer”).
